Abstract
Dermatomyositis (DM) is a rare autoimmune disease characterized by classic cutaneous manifestations and proximal muscle inflammation. Clinical symptoms are improved in many patients on treatments, but some experiences relapse. No consensus exists regarding the definition of a DM relapse. In practice, a relapse is diagnosed when the symptoms recur or worsen after first improving under treatment. Published data on both prevalence and risk factors of relapse in DM is limited. The aim of this study was to evaluate the frequency of relapse in DM and identify factors predicting relapse in patients with non-paraneoplastic DM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
